Impacts of Residual SNYTAX Score on The Clinical Outcomes following Percutaneous Coronary Intervention in Chronic Coronary Syndrome Patients

Wira Kimahesa Anggoro, Mohammad Saifur Rohman, Heny Martini, Pawik Supriadi, Cholid Tri Tjahjono, Yoga Waranugraha


Background: The residual SYNTAX score (RSS) can be used to measure the residual stenosis severity and complexity. The prognostic role of RSS in CCS patients is still unknown. We purposed to investigate the impact of RSS on the clinical outcomes following PCI in CCS patients.


Methods: A prospective cohort study was performed. Based on the residual SYNTAX score, patients were divided into three groups: RSS 0, RSS 0 to 9.5, and RSS >9.5. The primary outcome was patient-oriented composite endpoint (POCE), including repeat revascularization, myocardial infarction, and all-cause mortality.


Results: After 1-year follow-up period, patients in RSS >9.5 group revealed the greater POCE (4.3% vs. 6.4% vs. 23.9%; p = 0.016) than others. The repeat revascularization rate also was greater in the RSS >9.5 group (0.0% vs. 6.4% vs. 19.6%; p = 0.012). However, the hospitalization due to angina rates in all groups was not significantly different (4.3% vs. 4.2% vs. 4.3%; p = 1.000). The multivariate analysis revealed that RSS >9.5 was the strong predictor for repeat revascularization during 1 year follow-up (Odds ratio [OR] = 9.605; 95% confidence interval [CI] = 1.207 - 76.458; p = 0.033).


Conclusion: The greater RSS was associated with the higher 1-year POCE and repeat revascularization rate in CCS patients. The high RSS was also the strong predictor for 1-year repeat revascularization for CCS patients. 


Percutaneous Coronary Intervention; Chronic Coronary Syndrome; Residual Syntax Score

Full Text:



Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-477. doi:10.1093/eurheartj/ehz425

Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart. 2018;104(4):284-292. doi:10.1136/heartjnl-2017-311446

Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics—2020 Update: A Report from the American Heart Association. Circulation. 2020;141(9):e139-e596. doi:10.1161/CIR.0000000000000757

Hussain MA, Al Mamun A, Peters SA, Woodward M, Huxley RR. The Burden of Cardiovascular Disease Attributable to Major Modifiable Risk Factors in Indonesia. J Epidemiol. 2016;26(10):515-521. doi:10.2188/jea.JE20150178

Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol. 2012;60(24):e44-e164. doi:10.1016/j.jacc.2012.07.013

Serruys P, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009;5(1):50-56. doi:10.4244/EIJV5I1A9

Sianos G, Morel M-A, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219-227.

Franzone A, Taniwaki M, Rigamonti F, et al. Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial. EuroIntervention. 2016;12(5):e595-e604. doi:10.4244/EIJV12I5A99

Kobayashi Y, Lønborg J, Jong A, et al. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS. J Am Coll Cardiol. 2018;72(12):1321-1329. doi:10.1016/j.jacc.2018.06.069

Généreux P, Palmerini T, Caixeta A, et al. Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2012;59(24):2165-2174. doi:10.1016/j.jacc.2012.03.010

Altekin RE, Kilinc AY, Onac M, Cicekcibasi O. Prognostic Value of the Residual SYNTAX Score on In-Hospital and Follow-Up Clinical Outcomes in ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions. Chen R, ed. Cardiol Res Pract. 2020;2020:1-14. doi:10.1155/2020/9245431

Généreux P, Columbia University Medical Centre and The Cardiovascular Research Foundation, 111 East 59th St, 11th Floor, New York, NY 10022, US. E:; Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montréal, Palmerini T, et al. A Guide to Calculating SYNTAX Score. Interv Cardiol Rev. 2012;7(1):21-23. doi:10.15420/icr.2012.7.1.21

Park KW, Kang J, Kang S-H, et al. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry. Am Heart J. 2014;167(3):384-392.e5. doi:10.1016/j.ahj.2013.09.015

Ambrose JA, Singh M. Pathophysiology of coronary artery disease leading to acute coronary syndromes. F1000Prime Rep. 2015;7(8):1-5. doi:10.12703/P7-08

Knaapen P. Computed Tomography to Replace Invasive Coronary Angiography?: Close, but Not Close Enough. Circ Cardiovasc Imaging. 2019;12(2):e008710. doi:10.1161/CIRCIMAGING.119.008710

Bonello L, De Labriolle A, Lemesle G, et al. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Arch Cardiovasc Dis. 2009;102(2):143-151. doi:10.1016/j.acvd.2008.11.002

Prati F, Regar E, Mintz GS, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J. 2010;31(4):401-415. doi:10.1093/eurheartj/ehp433

Spaan JAE, Piek JJ, Hoffman JIE, Siebes M. Physiological Basis of Clinically Used Coronary Hemodynamic Indices. Circulation. 2006;113(3):446-455. doi:10.1161/CIRCULATIONAHA.105.587196

Simoons ML, Windecker S. Chronic stable coronary artery disease: drugs vs. revascularization. Eur Heart J. 2010;31(5):530-541. doi:10.1093/eurheartj/ehp605

Ahmad Y, Howard JP, Arnold A, et al. Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST‐Segment–Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta‐Analysis of Randomized Trials. J Am Heart Assoc. 2020;9(12):e015263. doi:10.1161/JAHA.119.015263

Dauerman HL. Reasonable Incomplete Revascularization. Circulation. 2011;123(21):2337-2340. doi:10.1161/CIRCULATIONAHA.111.033126

Capodanno D, Capranzano P, Giacchi G, Calvi V, Tamburino C. Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients. Int J Cardiol. 2013;167(4):1237-1241. doi:10.1016/j.ijcard.2012.03.148

Safarian H, Alidoosti M, Shafiee A, Salarifar M, Poorhosseini H, Nematipour E. The SYNTAX score can predict major adverse cardiac events following percutaneous coronary intervention. Heart Views. 2014;15(4):99. doi:10.4103/1995-705X.151081

Yan L, Li P, Wang Y, et al. Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency. Catheter Cardiovasc Interv. 2020;95(S1):606-615. doi:10.1002/ccd.28652

Takahashi K, Serruys PW, Fuster V, et al. Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation. The Lancet. 2020;396(10260):1399-1412. doi:10.1016/S0140-6736(20)32114-0



  • There are currently no refbacks.

Copyright (c) 2021 Wira Kimahesa Anggoro

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.